News

Filter

Current filters:

Immunologicals

1 to 9 of 274 results

Intarcia and Numab link up to develop once-yearly therapies in diabetes and other indications

20-03-2015

Privately-held US biotech firm Intarcia Therapeutics and Swiss firm Numab have announced a strategic…

BiotechnologyDiabetesImmunologicalsIntarcia TherapeuticsITCA 650LicensingMetabolicsNumab

Eli Lilly collaborates with Hanmi on BTK inhibitor

19-03-2015

US pharma major Eli Lilly and South Korean drugmaker Hanmi Pharmaceutical have entered into an exclusive…

Anti-Arthritics/RheumaticsEli LillyHanmi PharmaceuticalImmunologicalsLicensingPharmaceutical

Allergy Therapeutics announces share-placing to raise $30 million

Allergy Therapeutics announces share-placing to raise $30 million

10-03-2015

UK-based Allergy Therapeutics has announced a conditional placing of 94,117,650 placing shares to raise…

Allergy TherapeuticsFinancialImmunologicalsPharmaceuticalPollinex Quattro

Baxter acquires biopharmaceutical firm SuppreMol

Baxter acquires biopharmaceutical firm SuppreMol

04-03-2015

US health care product company Baxter International has acquired SuppreMol GmbH for 200 million euros…

Baxter InternationalBiotechnologyImmunologicalsSuppreMol

Amgen licenses AMG 714 to start-up Celimmune

Amgen licenses AMG 714 to start-up Celimmune

02-03-2015

USA-based biotech company Amgen has licensed a Phase II-stage anti-IL-15 monoclonal antibody, AMG 714,…

AmgenBiotechnologyGastro-intestinalsImmunologicalsLicensingUSA

UCB's full-year results

UCB's full-year results "confirm position of strength"

27-02-2015

The 2014 full-year financial results from Belgian drugmaker UCB “confirmed the position of strength”…

BelgiumCimziaFinancialImmunologicalsKeppraNeuproNeurologicalPharmaceuticalUCBVimpat

AstraZeneca inks deal with Orca for autoimmune disease drugs

AstraZeneca inks deal with Orca for autoimmune disease drugs

25-02-2015

Anglo-Swedish pharma major AstraZeneca and Orca Pharmaceuticals, a UK based biopharmaceutical company,…

AstraZenecaBiotechnologyImmunologicalsInflammatory diseasesLicensingOrca PharmaceuticalsRespiratory and PulmonaryUK

Intas becomes first Indian company to launch biosimilar in the EU

Intas becomes first Indian company to launch biosimilar in the EU

23-02-2015

Indian biopharma company Intas has become the first Indian company to launch a biosimilar in highly regulated…

BiosimilarsBiotechnologyFilgrastimHematologyImmunologicalsIndiaIntas PharmaceuticalsMarkets & MarketingRegulation

1 to 9 of 274 results

Back to top